Evaluate the Safety and Efficacy of Caspofungin Acetate as Empirical Therapy in Chinese Adults With Persistent Fever and Neutropenia (0991-055)
NCT00548080 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 131
Last updated 2015-12-17
Summary
Registration study
Conditions
Interventions
- DRUG
-
MK0991, caspofungin acetate / Duration of Treatment:
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Medical Monitor · Merck Sharp & Dohme LLC
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-03-31
- Primary Completion
- 2006-11-30
- Completion
- 2006-11-30
More Related Trials
-
A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074)
NCT01165320 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED)
NCT00717860 ·Status: COMPLETED ·Phase: PHASE3
-
Caspofungin Acetate in Treating Children With Fever and Neutropenia
NCT00020527 ·Status: COMPLETED ·Phase: NA
-
Caspofungin Study for Fungal Infections in Adults in Critical Care Settings
NCT00095316 ·Status: TERMINATED ·Phase: PHASE3
-
A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED)
NCT00250432 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia
NCT01982071 ·Status: TERMINATED ·Phase: PHASE4
-
Caspofungin or Micafungin as Empiric Antifungal Therapy for Persistent Fever and Neutropenia
NCT00723073 ·Status: COMPLETED
-
Efficacy and Safety of Caspofungin for Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmonary Disease
NCT01499433 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological Malignancy
NCT02895529 ·Status: TERMINATED ·Phase: PHASE4
-
MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients (0991-044)
NCT00082537 ·Status: COMPLETED ·Phase: PHASE2
-
Documented Candida or Aspergillus Infections in Pediatric Patients (0991-043)
NCT00082524 ·Status: COMPLETED ·Phase: PHASE2
-
Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment
NCT00008359 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Micafungin for Injection in Prevention and Treatment of Fungal Infection in Hematological Tumors
NCT04738955 ·Status: UNKNOWN ·Phase: PHASE4
-
Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp
NCT02646800 ·Status: TERMINATED ·Phase: PHASE4
-
A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal Infections
NCT02678598 ·Status: COMPLETED
-
Pharmacokinetics and Pharmacodynamics of Caspofungin (Cancidas ®) and Drug Tolerance of Fungi to Patients With an Invasive Fungal Infection in the Intensive Care Unit
NCT02510053 ·Status: UNKNOWN ·Phase: NA
-
Open, Pharmacokinetic Study of Caspofungin in Neonates and Infants (0991-058)
NCT00330395 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Study of Fungal Biomarkers (MK-0000-089)
NCT00854607 ·Status: COMPLETED
-
MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis (0991-037)
NCT00076869 ·Status: COMPLETED ·Phase: PHASE2
-
Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101)
NCT02180165 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetic, Safety and Efficacy of Intermittent Application of Caspofungin for Antifungal Prophylaxis
NCT01318148 ·Status: COMPLETED ·Phase: PHASE2
-
Post Marketing Study to Evaluate the Efficacy and Safety of Micafungin Treatment on Invasive Aspergillosis
NCT02646774 ·Status: TERMINATED ·Phase: PHASE4
-
Empirical Versus Preemptive Antifungal Therapy
NCT01288378 ·Status: COMPLETED ·Phase: PHASE3
-
Acetato de Caspofungin (Cancidas®) in the Treatment of Fungal Infection
NCT00388167 ·Status: COMPLETED
-
Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU)
NCT00520234 ·Status: COMPLETED ·Phase: PHASE4